Computational Medicine and Drug Designing Software - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB511242341

Publication Date:

November 6, 2024

Pages:

137

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

IT Services [2]

Computing & Electronics [3]

Description:

The global market for Computational Medicine and Drug Designing Software was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Computational Medicine and Drug Designing Software, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Computational Medicine and Drug Designing Software by region & country, by Type, and by Application.
The Computational Medicine and Drug Designing Software market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Computational Medicine and Drug Designing Software.
Market Segmentation
By Company
Entelos
Crown Bioscience
Chemical Computing Group
Nimbus Therapeutics
Schrodinger
Dassault Systemes
Genedata
Biognos
Leadscope
Rhenovia Pharma Limited
Compugen
Certara LP
Prosarix
Simulations Plus
Strand Life Sciences
Segment by Type:
Cloud-based
On-premise
Segment by Application
Drug Discovery and Development
Computational Physiological Medicine
Disease Modeling
Medical Imaging
Predictive Analysis of Drug Targets
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Computational Medicine and Drug Designing Software manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Computational Medicine and Drug Designing Software in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Computational Medicine and Drug Designing Software in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Market Overview
1.1 Computational Medicine and Drug Designing Software Product Introduction
1.2 Global Computational Medicine and Drug Designing Software Market Size Forecast
1.3 Computational Medicine and Drug Designing Software Market Trends & Drivers
1.3.1 Computational Medicine and Drug Designing Software Industry Trends
1.3.2 Computational Medicine and Drug Designing Software Market Drivers & Opportunity
1.3.3 Computational Medicine and Drug Designing Software Market Challenges
1.3.4 Computational Medicine and Drug Designing Software Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Computational Medicine and Drug Designing Software Players Revenue Ranking (2023)
2.2 Global Computational Medicine and Drug Designing Software Revenue by Company (2019-2024)
2.3 Key Companies Computational Medicine and Drug Designing Software Manufacturing Base Distribution and Headquarters
2.4 Key Companies Computational Medicine and Drug Designing Software Product Offered
2.5 Key Companies Time to Begin Mass Production of Computational Medicine and Drug Designing Software
2.6 Computational Medicine and Drug Designing Software Market Competitive Analysis
2.6.1 Computational Medicine and Drug Designing Software Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Computational Medicine and Drug Designing Software Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Computational Medicine and Drug Designing Software as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Cloud-based
3.1.2 On-premise
3.2 Global Computational Medicine and Drug Designing Software Sales Value by Type
3.2.1 Global Computational Medicine and Drug Designing Software Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Computational Medicine and Drug Designing Software Sales Value, by Type (2019-2030)
3.2.3 Global Computational Medicine and Drug Designing Software Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Drug Discovery and Development
4.1.2 Computational Physiological Medicine
4.1.3 Disease Modeling
4.1.4 Medical Imaging
4.1.5 Predictive Analysis of Drug Targets
4.2 Global Computational Medicine and Drug Designing Software Sales Value by Application
4.2.1 Global Computational Medicine and Drug Designing Software Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Computational Medicine and Drug Designing Software Sales Value, by Application (2019-2030)
4.2.3 Global Computational Medicine and Drug Designing Software Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Computational Medicine and Drug Designing Software Sales Value by Region
5.1.1 Global Computational Medicine and Drug Designing Software Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Computational Medicine and Drug Designing Software Sales Value by Region (2019-2024)
5.1.3 Global Computational Medicine and Drug Designing Software Sales Value by Region (2025-2030)
5.1.4 Global Computational Medicine and Drug Designing Software Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Computational Medicine and Drug Designing Software Sales Value, 2019-2030
5.2.2 North America Computational Medicine and Drug Designing Software Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Computational Medicine and Drug Designing Software Sales Value, 2019-2030
5.3.2 Europe Computational Medicine and Drug Designing Software Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Computational Medicine and Drug Designing Software Sales Value, 2019-2030
5.4.2 Asia Pacific Computational Medicine and Drug Designing Software Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Computational Medicine and Drug Designing Software Sales Value, 2019-2030
5.5.2 South America Computational Medicine and Drug Designing Software Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Computational Medicine and Drug Designing Software Sales Value, 2019-2030
5.6.2 Middle East & Africa Computational Medicine and Drug Designing Software Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Computational Medicine and Drug Designing Software Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Computational Medicine and Drug Designing Software Sales Value
6.3 United States
6.3.1 United States Computational Medicine and Drug Designing Software Sales Value, 2019-2030
6.3.2 United States Computational Medicine and Drug Designing Software Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Computational Medicine and Drug Designing Software Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Computational Medicine and Drug Designing Software Sales Value, 2019-2030
6.4.2 Europe Computational Medicine and Drug Designing Software Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Computational Medicine and Drug Designing Software Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Computational Medicine and Drug Designing Software Sales Value, 2019-2030
6.5.2 China Computational Medicine and Drug Designing Software Sales Value by Type (%), 2023 VS 2030
6.5.3 China Computational Medicine and Drug Designing Software Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Computational Medicine and Drug Designing Software Sales Value, 2019-2030
6.6.2 Japan Computational Medicine and Drug Designing Software Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Computational Medicine and Drug Designing Software Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Computational Medicine and Drug Designing Software Sales Value, 2019-2030
6.7.2 South Korea Computational Medicine and Drug Designing Software Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Computational Medicine and Drug Designing Software Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Computational Medicine and Drug Designing Software Sales Value, 2019-2030
6.8.2 Southeast Asia Computational Medicine and Drug Designing Software Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Computational Medicine and Drug Designing Software Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Computational Medicine and Drug Designing Software Sales Value, 2019-2030
6.9.2 India Computational Medicine and Drug Designing Software Sales Value by Type (%), 2023 VS 2030
6.9.3 India Computational Medicine and Drug Designing Software Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Entelos
7.1.1 Entelos Profile
7.1.2 Entelos Main Business
7.1.3 Entelos Computational Medicine and Drug Designing Software Products, Services and Solutions
7.1.4 Entelos Computational Medicine and Drug Designing Software Revenue (US$ Million) & (2019-2024)
7.1.5 Entelos Recent Developments
7.2 Crown Bioscience
7.2.1 Crown Bioscience Profile
7.2.2 Crown Bioscience Main Business
7.2.3 Crown Bioscience Computational Medicine and Drug Designing Software Products, Services and Solutions
7.2.4 Crown Bioscience Computational Medicine and Drug Designing Software Revenue (US$ Million) & (2019-2024)
7.2.5 Crown Bioscience Recent Developments
7.3 Chemical Computing Group
7.3.1 Chemical Computing Group Profile
7.3.2 Chemical Computing Group Main Business
7.3.3 Chemical Computing Group Computational Medicine and Drug Designing Software Products, Services and Solutions
7.3.4 Chemical Computing Group Computational Medicine and Drug Designing Software Revenue (US$ Million) & (2019-2024)
7.3.5 Nimbus Therapeutics Recent Developments
7.4 Nimbus Therapeutics
7.4.1 Nimbus Therapeutics Profile
7.4.2 Nimbus Therapeutics Main Business
7.4.3 Nimbus Therapeutics Computational Medicine and Drug Designing Software Products, Services and Solutions
7.4.4 Nimbus Therapeutics Computational Medicine and Drug Designing Software Revenue (US$ Million) & (2019-2024)
7.4.5 Nimbus Therapeutics Recent Developments
7.5 Schrodinger
7.5.1 Schrodinger Profile
7.5.2 Schrodinger Main Business
7.5.3 Schrodinger Computational Medicine and Drug Designing Software Products, Services and Solutions
7.5.4 Schrodinger Computational Medicine and Drug Designing Software Revenue (US$ Million) & (2019-2024)
7.5.5 Schrodinger Recent Developments
7.6 Dassault Systemes
7.6.1 Dassault Systemes Profile
7.6.2 Dassault Systemes Main Business
7.6.3 Dassault Systemes Computational Medicine and Drug Designing Software Products, Services and Solutions
7.6.4 Dassault Systemes Computational Medicine and Drug Designing Software Revenue (US$ Million) & (2019-2024)
7.6.5 Dassault Systemes Recent Developments
7.7 Genedata
7.7.1 Genedata Profile
7.7.2 Genedata Main Business
7.7.3 Genedata Computational Medicine and Drug Designing Software Products, Services and Solutions
7.7.4 Genedata Computational Medicine and Drug Designing Software Revenue (US$ Million) & (2019-2024)
7.7.5 Genedata Recent Developments
7.8 Biognos
7.8.1 Biognos Profile
7.8.2 Biognos Main Business
7.8.3 Biognos Computational Medicine and Drug Designing Software Products, Services and Solutions
7.8.4 Biognos Computational Medicine and Drug Designing Software Revenue (US$ Million) & (2019-2024)
7.8.5 Biognos Recent Developments
7.9 Leadscope
7.9.1 Leadscope Profile
7.9.2 Leadscope Main Business
7.9.3 Leadscope Computational Medicine and Drug Designing Software Products, Services and Solutions
7.9.4 Leadscope Computational Medicine and Drug Designing Software Revenue (US$ Million) & (2019-2024)
7.9.5 Leadscope Recent Developments
7.10 Rhenovia Pharma Limited
7.10.1 Rhenovia Pharma Limited Profile
7.10.2 Rhenovia Pharma Limited Main Business
7.10.3 Rhenovia Pharma Limited Computational Medicine and Drug Designing Software Products, Services and Solutions
7.10.4 Rhenovia Pharma Limited Computational Medicine and Drug Designing Software Revenue (US$ Million) & (2019-2024)
7.10.5 Rhenovia Pharma Limited Recent Developments
7.11 Compugen
7.11.1 Compugen Profile
7.11.2 Compugen Main Business
7.11.3 Compugen Computational Medicine and Drug Designing Software Products, Services and Solutions
7.11.4 Compugen Computational Medicine and Drug Designing Software Revenue (US$ Million) & (2019-2024)
7.11.5 Compugen Recent Developments
7.12 Certara LP
7.12.1 Certara LP Profile
7.12.2 Certara LP Main Business
7.12.3 Certara LP Computational Medicine and Drug Designing Software Products, Services and Solutions
7.12.4 Certara LP Computational Medicine and Drug Designing Software Revenue (US$ Million) & (2019-2024)
7.12.5 Certara LP Recent Developments
7.13 Prosarix
7.13.1 Prosarix Profile
7.13.2 Prosarix Main Business
7.13.3 Prosarix Computational Medicine and Drug Designing Software Products, Services and Solutions
7.13.4 Prosarix Computational Medicine and Drug Designing Software Revenue (US$ Million) & (2019-2024)
7.13.5 Prosarix Recent Developments
7.14 Simulations Plus
7.14.1 Simulations Plus Profile
7.14.2 Simulations Plus Main Business
7.14.3 Simulations Plus Computational Medicine and Drug Designing Software Products, Services and Solutions
7.14.4 Simulations Plus Computational Medicine and Drug Designing Software Revenue (US$ Million) & (2019-2024)
7.14.5 Simulations Plus Recent Developments
7.15 Strand Life Sciences
7.15.1 Strand Life Sciences Profile
7.15.2 Strand Life Sciences Main Business
7.15.3 Strand Life Sciences Computational Medicine and Drug Designing Software Products, Services and Solutions
7.15.4 Strand Life Sciences Computational Medicine and Drug Designing Software Revenue (US$ Million) & (2019-2024)
7.15.5 Strand Life Sciences Recent Developments
8 Industry Chain Analysis
8.1 Computational Medicine and Drug Designing Software Industrial Chain
8.2 Computational Medicine and Drug Designing Software Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Computational Medicine and Drug Designing Software Sales Model
8.5.2 Sales Channel
8.5.3 Computational Medicine and Drug Designing Software Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Entelos
Crown Bioscience
Chemical Computing Group
Nimbus Therapeutics
Schrodinger
Dassault Systemes
Genedata
Biognos
Leadscope
Rhenovia Pharma Limited
Compugen
Certara LP
Prosarix
Simulations Plus
Strand Life Sciences

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂